Treating endometriosis pain: stepped medical approach and integrative options
Key Takeaways
Medical treatment of endometriosis pain follows a stepped approach: NSAIDs and continuous combined hormonal contraceptives in first line, dienogest in second line, GnRH agonists with mandatory add-back in third line for refractory cases, and aromatase inhibitors in selected situations. Pelvic floor physiotherapy and cognitive behavioural therapy complement the medical strategy. In adolescents, early hormonal treatment is first line per ESHRE 2022. Doses are individualised by your doctor.
Key evidence: ESHRE guideline: endometriosis (2022) WHO endometriosis fact sheet
On this page
- Why a stepped approach
- First line: NSAIDs and combined hormonal contraceptives
- Second line: progestins
- Third line: GnRH agonists with add-back
- Aromatase inhibitors: a niche option
- Integrative approaches
- Special case: adolescents
- In practice
Why a stepped approach
Endometriosis pain involves multiple physiological mechanisms:
- Inflammation: Cyclic pelvic pain driven by inflammatory cytokines.
- Mechanical strain: Deep lesions and structural adhesions.
- Neuropathic sensitization: Central pain processing changes after chronic exposure.
- Myofascial dysfunction: Pelvic floor muscle hypertonicity and tension.
No single medication resolves all pain components. ESHRE 2022 guidelines recommend a stepped treatment strategy tailored to individual pain levels, side-effect profiles, and immediate fertility goals.
For diagnostic steps, visit our complete endometriosis guide and symptom overview.
First line: NSAIDs and combined hormonal contraceptives
Non-steroidal anti-inflammatory drugs (NSAIDs)
- Used on-demand during acute painful episodes.
- Inhibit inflammatory prostaglandin production in pelvic tissue.
- Limit: Prolonged high-dose use carries gastric, renal, and cardiovascular risks and does not arrest disease progression.
Combined hormonal contraceptives (CHC)
ESHRE 2022 guidelines strongly recommend combined hormonal contraceptives as first-line therapy:
- Delivery options: Combined oral pills, transdermal patches, or vaginal rings.
- Continuous regimen: Prescribed continuously without monthly placebo breaks to suppress menstruation completely.
- Benefit: Significantly reduces dysmenorrhea, pelvic pain, and pain during intercourse.
Standard contraindications apply (history of thrombosis, migraine with aura, uncontrolled hypertension, or smoking over age 35).
Second line: progestins
Dienogest 2 mg/day
Dienogest is a targeted progestin developed specifically for endometriosis management.
- Efficacy: Clinical trials (Strowitzki et al. 2010) demonstrate pain reduction equal to GnRH agonists.
- Tolerability: Maintains better long-term bone density than GnRH agonists.
- Side effects: Initial irregular spotting, mild weight changes, or transient mood shifts.
Alternative Progestin Options
- Levonorgestrel-releasing IUS (LNG-IUS): Excellent choice for local uterine suppression and coexisting adenomyosis.
- Etonogestrel implant: Long-acting subdermal progestin.
- Oral progestins: Norethindrone acetate or medroxyprogesterone acetate.
Third line: GnRH agonists with add-back
GnRH agonists (leuprolide, triptorelin, goserelin) induce temporary suppression of ovarian estrogen production.
Because estrogen suppression can cause hot flashes and bone density loss (~6% annually), strict prescribing protocols apply:
- Indication: Reserved for refractory pain when first- and second-line options fail.
- Mandatory add-back therapy: Co-prescribed from day one with low-dose estrogen/progestin or norethindrone to protect bone density.
- Treatment window: Limited to 6 to 12 months.
Aromatase inhibitors: a niche option
Aromatase inhibitors (letrozole, anastrozole) suppress local estrogen production within endometriotic implants.
- Postmenopausal patients: May be prescribed as monotherapy for residual disease pain.
- Pre-menopausal patients: Must always be combined with a progestin or oral contraceptive to prevent ovarian cyst formation.
Integrative approaches
Medical therapy is enhanced when combined with targeted supportive therapies:
- Pelvic floor physiotherapy: Treats pelvic floor muscle hypertonicity and musculoskeletal pelvic pain.
- Cognitive behavioral therapy (CBT): Helps manage chronic central pain processing, anxiety, and quality-of-life impact.
- Dietary adjustments: A balanced, anti-inflammatory diet supports general health but does not replace medical treatment.
Special case: adolescents
Severe dysmenorrhea causing school absence in adolescents warrants prompt evaluation.
- Initiate continuous combined contraceptives or progestins as first-line therapy.
- Consider LNG-IUS insertion for long-term symptom control.
- Reserve diagnostic surgery strictly for cases failing medical therapy.
Clinical Note
Pain management in endometriosis must balance symptom control with the patient’s immediate fertility plans.
Hormonal suppressive treatments (such as dienogest or GnRH agonists) provide effective pain relief, but they also prevent pregnancy.
If pregnancy is desired, suppressive therapy is stopped and fertility evaluation takes priority.
Dr. Senai Aksoy
In practice
- Step 1: NSAIDs on demand + continuous combined oral contraceptives or vaginal ring.
- Step 2: Dienogest 2 mg daily or LNG-IUS insertion.
- Step 3: GnRH agonist therapy paired with mandatory add-back protection for 6 to 12 months.
- Integrative support: Pelvic floor physical therapy and CBT to address myofascial and central pain.
FAQ
What is first-line treatment for pain?
NSAIDs on demand during painful periods, combined with a continuous combined hormonal contraceptive (pill, ring or patch, no monthly break) to suppress menstruation. That is the strong ESHRE 2022 recommendation.
Does dienogest cause weight gain?
Modest weight gain is possible but not systematic. Irregular bleeding is more frequent, especially early in treatment, before many patients transition to a well-tolerated amenorrhoea. Other common side effects include mood changes and sometimes lower libido.
Do GnRH agonists cause bone loss?
Yes, about 6 % per year without add-back, which is significant. That is why add-back with norethisterone or low-dose oestrogen plus progestin is now standard from day one, and treatment duration is limited to 6 to 12 months.
Can I become pregnant while on treatment?
Most suppressive hormonal treatments (CHC, dienogest, GnRH agonists) prevent pregnancy. If you have pregnancy plans, the treatment plan should be discussed and adjusted with your doctor. High-dose NSAIDs should be avoided when trying to conceive.
Does a specific diet help?
No specific diet has demonstrated solid clinical benefit. A balanced, broadly anti-inflammatory dietary pattern (fruits, vegetables, omega-3 fats, limited ultra-processed foods) can be part of a general approach without replacing validated medical treatments.
Is pelvic floor physiotherapy useful?
Yes, when a myofascial component is present — pelvic floor hypertonicity, musculoskeletal dyspareunia, residual pain after surgery. ESHRE 2022 recommends it as part of integrated care.
What if nothing works?
When successive medical steps and integrative care are insufficient, laparoscopic surgery may be discussed to treat lesions directly (excision rather than ablation), particularly in documented deep endometriosis. An expert centre is helpful in these situations.
My adolescent daughter has severe period pain — should we be concerned?
Disabling dysmenorrhoea in an adolescent, especially with school absenteeism or pain not responding to standard analgesics, should raise suspicion of early-onset endometriosis. First-line hormonal treatment (combined contraceptive or progestin) is recommended by ESHRE 2022 in this context.
Sources
- Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Human Reproduction Open 2022;2022(2):hoac009.
- Strowitzki T, Marr J, Gerlinger C, et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis. Hum Reprod 2010;25(3):633–641.
- WHO. Endometriosis Fact Sheet, March 2023.
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.